Riskpilot← Back to searchSign inGet full accessN.Esfahani AB
ABIn liquidationOrg 5593108300FalunEconomic activity was not specified by tax authority · NACE 0000Est. 20210 employees
Revenue 2024
SEK 238K
+505% vs 2023
EBITDA margin
93.9%
+4274% vs 2023
Equity ratio
60.7%
Financial strength
Net profit 2024
SEK 176K
+8390% vs 2023
| Revenue | SEK 238K | +505% |
| EBITDA | SEK 224K | +4274% |
| Net profit | SEK 176K | +8390% |
| Total assets | SEK 348K | +289% |
| Equity | SEK 211K | +509% |
| Employees | 0 | — |
Legal name
N.Esfahani AB
Org number
5593108300
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
7 april 2021
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknarna
Company purpose
Aktiebolaget skall utöva medicinsk verksamhet, bedriva hälso- och sjukvård, utbildning, konsultverksamhet inom dessa områden samt handel med aktier och värdepapper och förenlig verksamhet. Bolaget skall också bedriva juridisk konsultation och utbildning samt därmed förenlig verksamhet.
Address
Falun
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 49 | 39 | 238 |
| Staff expenses | −0 | — | — | −4 |
| EBITDA | — | 30 | 5 | 224 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 0 | 30 | 5 | 224 |
| Net financials | — | — | −0 | −1 |
| Profit before tax | 0 | 30 | 5 | 222 |
| Tax | — | −18 | −7 | −46 |
| Net profit | 0 | 12 | −2 | 176 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 25 | 43 | 89 | 348 |
| Equity | 25 | 37 | 35 | 211 |
| Long-term debt | 0 | 0 | — | — |
| Short-term debt | 0 | 6 | 55 | 137 |
| Total debt | — | 6 | 55 | 137 |
EBITDA margin
93.9%
This company
15.8%
Market median
+494% vs market
20212024
Equity ratio
60.7%
This company
38.2%
Market median
+59% vs market
20212024
Return on equity
83.6%
This company
18.4%
Market median
+354% vs market
20212024
Net profit margin
74.1%
This company
8.1%
Market median
+815% vs market
20212024
Asset turnover
0.68×
This company
1.12×
Market median
-39% vs market
20212024
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-04-07 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
LB External Signatory | External Signatory | 2025 |
BJ External Signatory | External Signatory | 2025 |
AE External Signatory | External Signatory | 2025 |
UM External Signatory | External Signatory | 2025 |
EJ Liquidator | Liquidator | 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of N.Esfahani AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Killgren Jonsson | External Signatory | 0 companies |
| Bengt Junior Niklas Nygårds | External Signatory | 0 companies |
| Anna Elisabet Viktoria Björk | External Signatory | 0 companies |
| Ulrika Margareta Ahlholm | External Signatory | 0 companies |
| Emma Johanna Karin Carlstedt Haga | Liquidator | 0 companies |
| Nakisa Esfahani | Board of Directors | 0 companies |
| Niosha Esfahani | Deputy Board Member | 0 companies |